Paritaprevir

Contraindicated

Paritaprevir Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of fatal toxicity Details Paritaprevir Simvastatin Flolipid Explained Increased risk of myopathy, including rhabdomyolysis Details Paritaprevir Dihydroergotamine Injection DHE-45® Injection Increased dihydroergotamine exposure and an increased risk of dihydroergotamine-related adverse effects Details Paritaprevir Dihydroergotamine Nasal Spray Migranal Increased dihydroergotamine exposure and an increased risk of dihydroergotamine-related adverse effects Details Paritaprevir Finerenone Kerendia Increased finerenone exposure and an increased risk of finerenone-related adverse effects Details Paritaprevir Ivabradine Corlanor Increased ivabradine exposure and an increased risk of ivabradine-related adverse effects [like bradycardia and conduction disturb... Details Paritaprevir Levonorgestrel After banger An increased risk of ALT elevation Details Paritaprevir Levonorgestrel Intrauterine System Kyleena An increased risk of ALT elevation Details Paritaprevir Lovastatin Altocor® Increased lovastatin exposure and an increased risk of lovastatin-related adverse effects, such as risk of myopathy and rhabdomyol... Details Paritaprevir Lurasidone Latuda Increased lurasidone exposure Details Paritaprevir Naloxegol Movantik Increased naloxegol exposure and an increased risk of naloxegol-related adverse effects Details

Major

Paritaprevir Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Paritaprevir Abametapir Explained Increased exposure of CYP3A4 substrate Details Paritaprevir Omeprazole Gastrobim Explained Increased paritaprevir exposure; decreased omeprazole exposure Details Paritaprevir Alpelisib Piqray Increased alpelisib exposure and an increased risk of alpelisib-related adverse effects and toxicity Details Paritaprevir Apixaban Eliquis Explained Increased apixaban exposure Details Paritaprevir Aripiprazole Injection Abilify Increased ARIPiprazole exposure Details Paritaprevir Asciminib Scemblix Increased asciminib exposure and an increased risk of asciminib-related adverse effects Details Paritaprevir Atogepant Qulipta Increased atogepant exposure Details Paritaprevir Avapritinib Ayvakit Increased avapritinib exposure and increased incidence and severity of adverse reactions Details Paritaprevir Cariprazine Vraylar Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Paritaprevir Amlodipine Amvaz® Increased amLODIPine exposure and an increased risk of hypotension and edema Details Paritaprevir Beclomethasone Nasal Spray Beconase Increased beclomethasone exposure and an increased risk of beclomethasone-related adverse reactions Details Paritaprevir Beclomethasone Oral Inhalation Beclovent® Increased beclomethasone exposure and an increased risk of beclomethasone-related adverse reactions Details Paritaprevir Bedaquiline Sirturo Increased bedaquiline exposure Details Paritaprevir Brexpiprazole Rexulti Increased brexpiprazole exposure Details Paritaprevir Budesonide Entocort Increased budesonide exposure Details Paritaprevir Budesonide Nasal Spray Rhinocort Increased budesonide exposure Details Paritaprevir Budesonide Oral Inhalation Pulmicort Increased budesonide exposure Details Paritaprevir Cabozantinib Cabometyx Increased cabozantinib exposure and an increased risk of cabozantinib-related adverse reactions Details Paritaprevir Cabozantinib (Thyroid Cancer) Cabometyx Increased cabozantinib exposure and an increased risk of cabozantinib-related adverse reactions Details Paritaprevir Cyclosporine Injection Atopica Increased exposure of cycloSPORINE and paritaprevir Details Paritaprevir Cyclosporine Ophthalmic Cequa Increased exposure of cycloSPORINE and paritaprevir Details Paritaprevir Darolutamide Nubeqa Increased exposure of OATP1B1 or OATP1B3 substrates Details Paritaprevir Dasatinib Phyrago Increased dasatinib exposure and an increased risk of dasatinib-related adverse effects Details Paritaprevir Disopyramide Norpace Increased exposure of antiarrhythmic drug Details Paritaprevir Docetaxel Beizray Increased DOCEtaxel exposure Details Paritaprevir Docetaxel Injection Beizray Increased DOCEtaxel exposure Details Paritaprevir Doxorubicin Adriamycin Increased doxorubicin exposure and an increased risk of doxorubicin-related adverse reactions Details Paritaprevir Eluxadoline Viberzi Increased eluxadoline exposure Details